These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15043392)

  • 1. Severe acute respiratory syndrome: scientific and anecdotal evidence for drug treatment.
    Tsang K; Seto WH
    Curr Opin Investig Drugs; 2004 Feb; 5(2):179-85. PubMed ID: 15043392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Targets and studies on anti-SARS drugs].
    Du GH; Wang W; Cheng KD; Cao LL; Yang XY; Zhu P
    Yao Xue Xue Bao; 2004 Mar; 39(3):236-40. PubMed ID: 15171664
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of antiviral therapy for severe acute respiratory syndrome.
    Cinatl J; Michaelis M; Hoever G; Preiser W; Doerr HW
    Antiviral Res; 2005 Jun; 66(2-3):81-97. PubMed ID: 15878786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].
    Ye ZW; Jin DY
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):571-592. PubMed ID: 32347053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic treatment of SARS: current knowledge and recommendations.
    Tai DY
    Ann Acad Med Singap; 2007 Jun; 36(6):438-43. PubMed ID: 17597972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment and vaccines for severe acute respiratory syndrome.
    Groneberg DA; Poutanen SM; Low DE; Lode H; Welte T; Zabel P
    Lancet Infect Dis; 2005 Mar; 5(3):147-55. PubMed ID: 15766649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broad-spectrum coronavirus antiviral drug discovery.
    Totura AL; Bavari S
    Expert Opin Drug Discov; 2019 Apr; 14(4):397-412. PubMed ID: 30849247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe acute respiratory syndrome treatment: present status and future strategy.
    Lau AC; So LK
    Curr Opin Investig Drugs; 2003 Aug; 4(8):918-20. PubMed ID: 14508874
    [No Abstract]   [Full Text] [Related]  

  • 9. Remdesivir against COVID-19 and Other Viral Diseases.
    Malin JJ; Suárez I; Priesner V; Fätkenheuer G; Rybniker J
    Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33055231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experience with empirical treatment of severe acute respiratory syndrome due to coronavirus, genotype IV].
    Shchukina VN; Loginova SIa; Borisevich SV; Bondarev VP
    Antibiot Khimioter; 2011; 56(7-8):42-6. PubMed ID: 22359870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments in the virology and antiviral research of severe acute respiratory syndrome coronavirus.
    Yeung KS; Meanwell NA
    Infect Disord Drug Targets; 2007 Mar; 7(1):29-41. PubMed ID: 17346209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug targets in severe acute respiratory syndrome (SARS) virus and other coronavirus infections.
    Tong TR
    Infect Disord Drug Targets; 2009 Apr; 9(2):223-45. PubMed ID: 19275708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacotherapy of severe acute respiratory syndrome (SARS)].
    von Hagen L; Pletz MW; Dickgreber N; Golpon H; Bauer TT; Zabel P; Welte T; Groneberg DA
    Pneumologie; 2006 Nov; 60(11):694-700. PubMed ID: 17109267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What are our pharmacotherapeutic options for MERS-CoV?
    Al-Tawfiq JA; Memish ZA
    Expert Rev Clin Pharmacol; 2014 May; 7(3):235-8. PubMed ID: 24580083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV: Lessons learned; opportunities missed for SARS-CoV-2.
    Davis IM
    Rev Med Virol; 2021 Jan; 31(1):1-6. PubMed ID: 32808446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lupus pneumonitis or severe acute respiratory syndrome?
    Mok CC; Ying KY
    Lupus; 2004; 13(7):549-53. PubMed ID: 15352429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of anti-SARS agents.
    Shigeta S; Yamase T
    Antivir Chem Chemother; 2005; 16(1):23-31. PubMed ID: 15739619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infectious diseases. One year after outbreak, SARS virus yields some secrets.
    Enserink M
    Science; 2004 May; 304(5674):1097. PubMed ID: 15155925
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of the efficacy and safety of Ribavirin in treatment of coronavirus-related pneumonia (SARS, MERS and COVID-19): A protocol for systematic review and meta-analysis.
    Wang Y; Li W; Jiang Z; Xi X; Zhu Y
    Medicine (Baltimore); 2020 Sep; 99(38):e22379. PubMed ID: 32957417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentoxifylline and severe acute respiratory syndrome (SARS): a drug to be considered.
    Bermejo Martin JF; Jimenez JL; Muńoz-Fernández A
    Med Sci Monit; 2003 Jun; 9(6):SR29-34. PubMed ID: 12824965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.